Science

Projects

DAL-GenE Phase III, double-blind, randomized placebo-controlled study to evaluate the effects of dalcetrapib on cardiovascular risk in a genetically defined population with a recent acute coronary syndrome. The Dal-GenE clinical…

Publications

2018 Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort.¬†Shahabi, P., Lamothe, F., Dumas, S., Rouleau-Mailloux, E., Feroz Zada, Y., Provost, S., Asselin, G., Mongrain, I.,…